Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron

被引：0
|
作者：
Manuela Di Fusco
Xiaowu Sun
Mary M. Moran
Henriette Coetzer
Joann M. Zamparo
Mary B. Alvarez
Laura Puzniak
Ying P. Tabak
Joseph C. Cappelleri
机构：
[1] Pfizer Inc,Health Economics and Outcomes Research
[2] CVS Health,Field Medical Outcomes and Analytics
[3] Pfizer Inc,MDSCA Vaccines
[4] Pfizer Inc,Statistical Research and Data Science Center
[5] Pfizer Inc,undefined
[6] Pfizer Inc,undefined
来源：
Journal of Patient-Reported Outcomes | / 7卷
关键词：
COVID-19; SARS-CoV-2; COVID-19 symptoms; Long COVID; BNT162b2; Booster vaccine; HRQoL; WPAI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] MODELING THE POTENTIAL PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF BNT162B2 COVID-19 BOOSTER VACCINATION IN MEXICO
    Huerta, J.
    Mendoza, C. F.
    Kyaw, M. H.
    Becerra, R. A.
    Abreu, D.
    Chirila, I
    Yarnoff, B.
    VALUE IN HEALTH, 2024, 27 (12) : S104 - S104
  • [22] Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19
    Kang, Kyusik
    Lee, Jung-Ju
    Kim, Byung-Kun
    JOURNAL OF CLINICAL NEUROLOGY, 2022, 18 (06): : 723 - 725
  • [23] Erythema exsudativum multiforme infolge einer COVID-19-Impfung (BNT162b2)Erythema multiforme following COVID-19 vaccination (BNT162b2)
    K. Wunderlich
    T. Dirschka
    Der Hautarzt, 2022, 73 (1): : 68 - 70
  • [24] Adverse reactions of BNT162b2 vaccine booster against COVID-19 in Japan
    Nishizawa, Toshinori
    Jinta, Torahiko
    Koyamada, Ryosuke
    Uehara, Yuki
    Taki, Fumika
    Arioka, Hiroko
    JOURNAL OF GENERAL AND FAMILY MEDICINE, 2022, 23 (05): : 360 - 362
  • [25] Protection against Covid-19 by BNT162b2 Booster across Age Groups
    Bar-On, Yinon M.
    Goldberg, Yair
    Mandel, Micha
    Bodenheimer, Omri
    Freedman, Laurence
    Alroy-Preis, Sharon
    Ash, Nachman
    Huppert, Amit
    Milo, Ron
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26): : 2421 - 2430
  • [26] Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel
    Mevorach, Dror
    Anis, Emilia
    Cedar, Noa
    Hasin, Tal
    Bromberg, Michal
    Goldberg, Lital
    Levi, Nir
    Perzon, Ofer
    Magadle, Nur
    Barhoum, Barhoum
    Parnassa, Elchanan
    Dichtiar, Rita
    Hershkovitz, Yael
    Green, Manfred S.
    Ash, Nachman
    Keinan-Boker, Lital
    Alroy-Preis, Sharon
    CIRCULATION, 2022, 146 (10) : 802 - 804
  • [27] Acute hepatitis following mRNA BNT162b2 COVID-19 vaccination
    Cheah, Matthew
    Girgis, Safwat
    Bain, Vincent G.
    CANADIAN LIVER JOURNAL, 2022, 5 (04): : 535 - 539
  • [28] Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
    Fotiadou, Aggeliki
    Tsiptsios, Dimitrios
    Kitmeridou, Sofia
    Mavraki, Eleni
    Iliopoulos, Ioannis
    NEUROLOGICAL SCIENCES, 2023, 44 (02) : 457 - 459
  • [29] BNT162b2 mRNA Covid-19 Vaccine - in a Nationwide Mass Vaccination Setting
    Roest, Stefan
    Hoek, Rogier A. S.
    Manintveld, Olivier C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20): : 1968 - 1970
  • [30] A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination
    King, Eleanor R.
    Towner, Elizabeth
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
12345